POSA133 Cost-Effectiveness of Dapagliflozin for the Treatment of Heart Failure with Reduced Ejection Fraction: Analyses from the Perspectives of France and the United States

Autor: Binnie, R, Omar Alsaleh, AJ
Zdroj: In Value in Health January 2022 25(1) Supplement:S60-S60
Databáze: ScienceDirect